Iridient Developer and Iridient Transformer Updated For macOS 11 Big Sur and Apple Silicon


Iridient Developer and all of the Iridient Transformer applications have been updated. These updates bring support for new RAW camera models, performance improvements and bug fixes. These releases are now all compatible with macOS 11 (Big Sur) beta versions on both Intel and Apple Silicon based systems (in emulation). Iridient Developer 3.4 features all new GPU based optimizations on macOS 10.13 and later systems with Metal compatible GPUs. Final macOS 11 optimizations and Apple Silicon native versions still await final Apple development tool releases which should be available soon.

Iridient Developer 3.4 is a free upgrade only for those who have purchased a license more recently than March 10, 2019. The latest Iridient Transformer updates are still free for all license holders even if you are now beyond the guaranteed 18 month free upgrade period.

Iridient Developer Version History
3.4 – September 25, 2020 (Major Update)

  • New Features:
    • Support added for macOS 11 (Big Sur) and compatibility with Apple Silicon based Macs in emulation.
    • Support added for CR3 images from the Canon EOS R5, EOS R6 and EOS 850D (Rebel T8i, Kiss X10i).
    • Support added for NEF images from the Nikon Z 5.
    • Support added for ARW images from the Sony a7C (ILCE-7C) and a7S III (ILCE-7SM3)
    • Support added for ORF images from the Olympus E-M10 Mark IV.
    • Support added for RW2 images from the Panasonic DC-S5 and DC-G100 (DC-G110).
    • Support added for DNG images from the Leica M10-R.
    • Support added for 3FR/FFF images from the Hasselblad CFV II 50C/907X.
  • Improvements:
    • Additional GPU (Metal) based performance optimizations for macOS 10.13 or later systems.
    • JPEG export libraries updated to new version (libjpeg-turbo 2.0.5).
    • Updated to the latest OpenEXR libraries (2.5.2).
    • Updated to the latest libraw version (0.2).
    • LittleCMS color management library updated to newest version (2.11).
    • Updated DNG color and white balance default metadata to the latest Adobe DNG Converter 12.4 release.

Iridient Developer Download

Iridient X-Transformer Version History
1.6.7 – September 25, 2020 (Maintenance Update)

  • Improvements:
    • Updated camera calibration and profile information for models newly supported in Adobe’s latest DNG Converter 12.4 update.
    • Updated to the latest version of the libjpeg-turbo library (2.0.5).
    • Updated to the latest version of the wxWdigets library (3.1.4).
    • Updated to the latest version of the LibreSSL library (3.1.4).
    • Updated build with latest Apple and Microsoft development tools.

Iridient X-Transformer Download

Please don’t forget to follow us on Facebook, Twitter, Instagram, YouTube

Plus our owners’ groups
Fujifilm GFX Owners Group
Fujifilm X-H Owners Group
Fujifilm X-T Owners Group
Fujifilm X-Pro Owners Group
Fujifilm X-E Owners Group
Fujifilm X-A Owners Group
Fujifilm X100 Owners Group

Posted in Software| Tagged , , , , , , , , , | Leave a comment

Save Up to $400 Off Previous Generation iPad Pro


You can save up to $400 on the previous generation iPad Pro at B&H Photo while supplies last. If you just want an iPad Pro you can get on here, but the bundles offer the biggest savings which can be found here. This is a great option if you want to give Lightroom mobile a try or any other iOS editing application. Some of the listings are already limited so there probably isn’t much stock left so don’t delay if you’re interested.

iPad Pro Bundles: B&H Photo
iPad Pro: B&H Photo

Posted in Deals| Tagged , | Leave a comment

New President and Managing Director for Fujifilm in Europe Toshihisa “Toshi” Iida


New President and Managing Director for Fujifilm in Europe
Toshihisa “Toshi” Iida appointed new President and Managing Director of Fujifilm in Europe as Masato “Mark” Yamamoto departs to take up a Board Director position at FUJIFILM Holdings Corporation, Tokyo, Japan.

Effective 1st September, Toshihisa “Toshi” Iida has taken up the position of President and Managing Director for FUJIFILM Europe GmbH, Düsseldorf, Germany, and FUJIFILM Europe B.V., Tilburg, Netherlands.

Toshi will be responsible for a wealth of businesses across the region, where Fujifilm operate 55 group companies in 43 countries, employing 4,500 people engaged in research and development, manufacturing, sales, marketing and service. Based in Düsseldorf, Germany, he will be responsible for all business divisions including Medical Systems, Photo Imaging and instax, Electronic Imaging, Optical Devices, Graphic Systems, Recording Media and Industrial Products, as well as new ventures that utilise a number of highly versatile core technologies originally developed from within Fujifilm’s photo film business. These include regenerative medicine, cell culture media and membrane technologies.

Born in 1967, Toshi joined Fujifilm in 1991 after graduating from Keio University and started his career with the International Marketing Division in the consumer film business. After progressing through various positions, his first overseas assignment was in Europe for Fujifilm UK between 1997 and 2005.

After returning to Japan in 2005, Toshi has had a long and prosperous career within the Electronic Imaging division and was appointed head of the division as well as the Optical Device division in 2016. He has been responsible for the growth and establishment of the renowned X Series brand, as well as the successful launch of GFX 100, Fujifilm’s mirrorless digital camera system launched in 2019, that has achieved the highest level of image quality in the world of professional photography.

Commenting on his appointment as President and Managing Director for FUJIFILM Europe GmbH and FUJIFILM Europe B.V, Toshi said:

“I’m very happy to join the European Fujifilm family. In these challenging times the role of the company is changing rapidly. Through this coronavirus pandemic, we have swiftly responded to new and dramatic needs from our customers and society, such as providing to healthcare organizations, medical devices and software solutions, powered by artificial intelligence, that support the workflow of those working on the front line and aim to save lives. In addition, at our Fujifilm Diosynth Biotechnologies sites in Denmark and the United Kingdom, we are putting in major efforts by working with our partners to accelerate the manufacture of potential future therapies and vaccines.

In our legacy businesses such as consumer photography, photo printing, optical devices and commercial printing, we have also exploited the unlimited potential of digital technologies to be anytime connected with our consumers, and we have started new ways of interacting with our European brand enthusiasts from X Series, GFX and FUJINON to instax – successfully launching new products.

Knowing how to quickly grasp the needs of society and respond promptly with creativity and passion is the mission I want to undertake in Fujifilm Europe with the collaboration of the entire organization. As I look to the future, I am confident that we are in a very good position to grow, particularly in Healthcare and Life Sciences. I am very proud to take on this task now at an important moment for Fujifilm – and the people of Europe – it is a fantastic opportunity.”

Toshi succeeds Mark Yamamoto who was appointed Managing Director of Fujifilm in Europe in May 2018, who will now take up a new assignment as a Board Director for FUJIFILM Holdings Corporation in Tokyo, Japan. He will also become the General Manager of Optical Device & Electronic Imaging Products Division.

Posted in Press releases| Tagged , | Leave a comment

Avigan Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19


Anti-influenza drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients
TOKYO, September 23, 2020 — FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter “FUJIFILM Toyama Chemical”) has announced today that primary endpoint has been met in phase III clinical trial of “Avigan Tablet” (generic name: favipiravir, “Avigan”) conducted in Japan for patients with novel coronavirus infections (hereinafter “COVID-19”). The efficacy primary endpoint is time to negative conversion of detectable SARS-CoV 2 viral RNA in the RT-PCR assays, and to alleviation of symptoms (body temperature, oxygen saturation and chest images).

FUJIFILM Toyama Chemical began a phase III clinical trial of Avigan in Japan in March 2020, for COVID-19 patients with non-severe pneumonia. The company conducted randomized, placebo-controlled, single-blind comparative study* to evaluate the efficacy and safety of Avigan.

The median value of primary endpoints, using 156 individuals as analysis targets, were 11.9 days for the Avigan group and 14.7 days for the placebo group. FUJIFILM Toyama Chemical confirmed, with a statistically significant difference (p value = 0.0136), that the administration of Avigan to COVID-19 patients with non-serious pneumonia demonstrates shorter time to resolution. The adjusted hazard ratio** showed 1.593 (95% confidence interval of 1.024 –2.479). No new safety concerns were noted in this trial.

FUJIFILM Toyama Chemical will conduct a detailed analysis of the data obtained in this trial, and will work to file Application for Partial Changes to include the additional indication in as early as October.

Approved for manufacture and sale in Japan as an influenza antiviral drug, Avigan, selectively inhibits RNA polymerase necessary for influenza virus replication. Due to this mechanism of action, it is expected that Avigan may have an antiviral effect on the new coronavirus, as they are RNA viruses of the same type as influenza viruses.

To meet the requests of the Japanese government to increase stockpiles of Avigan, and by other countries to supply the drug, the Fujifilm Group has been working to increase production of Avigan in collaboration with strategic partners. The Fujifilm Group will work to deliver the treatment drug to COVID-19 patients as soon as possible, and contribute to ending the spread of COVID-19.

*A trial in which the subjects are randomly allocated to a group receiving the actual drug or a group receiving a placebo, and a comparative investigation is made without informing the subjects about the drugs that had been allocated to them. In this trial, a comparison was made by administering Avigan and a placebo to the subjects, in addition to standard treatment.
**An indicator showing the relative risk of event occurrence by comparison is called a hazard ratio, and a ratio that adjusted the differences in background between the groups compared is called an adjusted hazard ratio. The hazard ratio used in this trial indicates the possibility of symptom relief and virologic responses turning negative. If the hazard ratio exceeds 1, administration of Avigan is judged to be more favorable.

Other Avigan/COVID-19/Fujifilm Biomedical Coverage ( 1, 2, 3, 4, 5, 6, 7, 8, 9,10. 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

Please don’t forget to follow us on Facebook, Twitter, Instagram, YouTube

Plus our owners’ groups
Fujifilm GFX Owners Group
Fujifilm X-H Owners Group
Fujifilm X-T Owners Group
Fujifilm X-Pro Owners Group
Fujifilm X-E Owners Group
Fujifilm X-A Owners Group
Fujifilm X100 Owners Group

Posted in Press releases| Tagged , , , , | Leave a comment

New Profoto A10 AirTTL-F Studio Light For Fujifilm With Bluetooth


The Profoto A10 AirTTL-F Studio Light for Fujifilm was announced today. You can get one at B&H Photo / Adorama. It can be used with the new Profoto connect transmitter B&H Photo / Adorama and older Profoto Air Remote TTL-F B&H Photo / Adorama.

Explora

Key Features
  • Built-In AirTTL, Use On or Off Camera
  • Fast Full-Power Recycling: 1 sec
  • Upgraded Battery: 450 Full-Power Flashes
  • Sync A10 Flash with iPhone Camera
  • High-Speed Sync, LED Modeling Light
  • 9-Stop Power Range, 76Ws Output
  • Weighs 1.2 lb Including Battery
  • Optional Wireless TTL with Air Remote
  • Includes Bounce Card, Dome Diffuser
  • A10 Bag with Shoulder Strap

Profoto A10 AirTTL-F: B&H Photo / Adorama
Profoto Connect Transmitter: B&H Photo  / Adorama
Profoto Air Remote TTL-F: B&H Photo / Adorama

Posted in Accessories, Fuji flashes| Tagged , , , , , , , , , , | Leave a comment

DPR: Instax SQ1 Review


DPReview posted their review of the Fujifilm Instax SQ1 which you can read in full here. Below are the bullet points:

Like

  • Easy-to-operate
  • Accurate exposures outdoors
  • Comfortable to hold and operate
  • Stylish look
  • Square format film

Don’t Like

  • Placement of shutter button
  • CR2 batteries can be difficult to find
  • No creative modes like double exposure or lighten/darken

You can also get the SQ6, which has a few more features like double exposures, landscape mode, lighten and darken modes, and a self-timer. Plus some of the color combinations are discounted.

Instax SQ1: Amazon / B&H Photo

Instax SQ6: B&H Photo / Amazon / Adorama

Fujifilm Instax Square: B&H Photo / Amazon / Adorama
Square Black Instant Film: B&H Photo / Amazon / Adorama
Instax Square White Marble Film: B&H Photo / Amazon

Posted in Instax| Tagged , , , , , , , , , , , , , , , , , , | Leave a comment